AllgemeinFocused MeetingNewsNewsHP

Digital Conference: Corona Vaccine – Impact of Nanotechnology

The focus meeting will be held as a digital conference on November 24.

A virus the size of a few nanometers paralyzes the whole world. Biotech companies and pharmaceutical companies are working flat out to develop a vaccine against the new coronavirus Sars-CoV-2, driven by funds and the expectations of governments worldwide. With the event “Corona Vaccine – Impact of Nanotechnology” organized by NINa SH we would like to inform you about current activities and research from science and industry in the cross-sectional area of ​​biotechnology and nanotechnology in vaccine development.

The presentations are each 25 minutes long. Subsequently the participants have the opportunity to ask questions.

Participation is free of charge, registration is required.


Date: 24 November 2020, Time: 2 pm

14:00 CET
Prof. Dr. Franz Faupel,
Chair for Multicomponent Materials, Kiel University /
Chairman North German Initiative Nanotechnology Schleswig-Holstein e.V.

14:05 CET
Vaccine development – what is nano in it?
Prof. Dr. Regina Scherließ,
Pharmaceutical Institute, Kiel University /
North German Initiative Nanotechnology Schleswig-Holstein e.V.

14:35 CET
Challenges in Engineering Therapeutic Antibodies
Prof. Dr. Matthias Peipp,
Section for stem cell- and immunotherapy, UKSH

15:05 CET
Detection of SARS-CoV-2 infections using a combination of virus and antibody analysis on a point-of-care biochip platform
Lars Blohm,
Campton Diagnostics

15:35 CET
Covid-19, microbial manufacturing options for vaccines and treatments
Dr. Thilo Kamphausen,
Richter-Helm BioLogics GmbH & Co. KG

16:05 CET
Wrap up and Closing


Dr. Christian Ohrt, NINa SH
Telefon: +49 431 880-6245


Digital Conferencing